PP
FOLD

PDT Partners’s Amicus Therapeutics FOLD Stock Holding History

PDT Partners’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Sell
75,318
-374,681
-83% -$5.37M 0.06% 322
2025
Q4 		$6.41M Sell
449,999
-56,053
-11% -$551K 0.42% 60
2025
Q3 		$3.99M Hold
506,052
– – 0.25% 141
2025
Q2 		$2.9M Sell
506,052
-235,263
-32% -$1.52M 0.16% 216
2025
Q1 		$6.05M Buy
741,315
+388,817
+110% +$3.6M 0.43% 40
2024
Q4 		$3.32M Buy
352,498
+99,539
+39% +$1.03M 0.29% 112
2024
Q3 		$2.7M Buy
+252,959
New +$2.75M 0.24% 140
2022
Q4 		– Sell
-30,505
Closed -$318K – 723
2022
Q3 		$318K Buy
+30,505
New +$340K 0.05% 566
2022
Q2 		– Sell
-32,921
Closed -$312K – 1021
2022
Q1 		$312K Buy
+32,921
New +$309K 0.03% 713
2019
Q3 		– Sell
-316,400
Closed -$3.95M – 465
2019
Q2 		$3.95M Hold
316,400
– – 0.23% 129
2019
Q1 		$4.3M Sell
316,400
-22,000
-7% -$269K 0.24% 125
2018
Q4 		$3.24M Buy
338,400
+245,816
+266% +$2.7M 0.18% 155
2018
Q3 		$1.12M Buy
+92,584
New +$1.29M 0.05% 301
2015
Q3 		– Sell
-227,026
Closed -$3.21M – 1365
2015
Q2 		$3.21M Buy
227,026
+92,357
+69% +$1.11M 0.08% 293
2015
Q1 		$1.47M Buy
134,669
+35,402
+36% +$312K 0.04% 580
2014
Q4 		$826K Sell
99,267
-14,033
-12% -$96.3K 0.08% 374
2014
Q3 		$674K Buy
+113,300
New +$594K 0.02% 844

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

PDT Partners's FOLD Position: Q1 2026 in Review

PDT Partners reduced its Amicus Therapeutics (FOLD) stake by 83% in Q1 2026, selling an estimated $5.37M and leaving 75,318 shares worth $1.09M. The position accounts for 0.06% of the portfolio, ranked #322.

PDT Partners first reported a position in FOLD in Q3 2014 and has held it in 17 quarters since. The position peaked at $6.41M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • PDT Partners held 75,318 shares of Amicus Therapeutics worth $1.09M as of Q1 2026.
  • PDT Partners sold 374,681 Amicus Therapeutics shares in Q1 2026, an estimated $5.37M.
  • Amicus Therapeutics made up 0.06% of PDT Partners's portfolio in Q1 2026, its #322 holding.
  • PDT Partners first reported a position in Amicus Therapeutics in Q3 2014 and has held it in 17 quarters since.
  • PDT Partners's Amicus Therapeutics position peaked at $6.41M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.